"Statin Nation" (2012) and "Statin Nation II" (2014) are documentary films by Justin Smith that challenge the evidence base for statin drugs and expose the conflicts of interest in cholesterol research.

The Films

"Statin Nation" examines the evidence for statin drugs and finds it far weaker than commonly presented. The films cover:

  • The history of the cholesterol hypothesis of heart disease
  • The evidence (and lack thereof) for statin drugs in primary prevention
  • The side effects of statins that are systematically understated
  • The conflicts of interest in cholesterol research and clinical guidelines
  • Alternative approaches to cardiovascular risk reduction

The Primary Prevention Problem

The films focus particularly on statin use in primary prevention — in people who have not yet had a heart attack. The evidence for primary prevention is weak:

  • Absolute risk reduction: approximately 1% over 5 years
  • Number needed to treat: 100 people for 5 years to prevent 1 cardiovascular event
  • No significant reduction in all-cause mortality in low-risk individuals

100 people must take statins for 5 years to prevent 1 cardiovascular event. 99 people receive no benefit but all 100 are exposed to the risks of muscle damage, cognitive impairment, and increased diabetes risk.

The Side Effect Problem

The films document statin side effects that are systematically understated in industry-funded trials:

  • Muscle pain and weakness (myalgia): affects 5-10% in clinical practice
  • Cognitive impairment and memory problems
  • Increased risk of type-2 diabetes (9% increased risk)
  • CoQ10 depletion (causing mitochondrial dysfunction)
  • Peripheral neuropathy

The Conflict of Interest Problem

The films document the extensive financial relationships between statin manufacturers and:

  • Clinical guideline authors
  • Medical journal editors
  • Continuing medical education providers
  • Patient advocacy groups
  • Regulatory agencies

The Alternative

The films present alternative approaches to cardiovascular risk reduction:

  • Dietary intervention (eliminating sugar and refined carbohydrates)
  • Exercise
  • Niacin (for HDL raising and triglyceride lowering)
  • Omega-3 fatty acids
  • Aspirin

These interventions address the underlying causes of cardiovascular disease rather than merely lowering a biomarker.